Search Results

Business

Beckman Coulter and MeMed Extend Partnership Advancing Host Immune Response Diagnostics

Beckman Coulter Diagnostics, a global leader in clinical diagnostics, and MeMed, a leader in the emerging field of advanced host-response technologies, announced expansion of their host immune response diagnostics partnership.

May 7, 2024

·

5 min read

Business

MeMed Bolsters Leadership Team With Appointment of Ori Hadomi as Chairman and Peter Scheu as President of MeMed US

MeMed announces the appointment of Mr. Ori Hadomi as Chairman of the Board of Directors and Mr. Peter Scheu, as President of MeMed US.

November 6, 2023

·

2 min read

Policy

MeMed awarded US BARDA contract to demonstrate clinical utility of the FDA-cleared MeMed BV® test for distinguishing bacterial from viral infections

MeMed is pleased to announce that it has been awarded a contract valued at $727,799 by the Division of Research, Innovation, and Ventures of the U.S. Department of Health and Human Services, Biomedical Advanced Research and Development Authority.

October 24, 2023

·

2 min read

FDA

MeMed: FDA Clears Pioneering MeMed BV Test Direct From Whole Blood Allowing Faster Time To Result And Broader Patient Access When Distinguishing Bacterial From Viral Infections

MeMed, a leader in the emerging field of advanced host response technologies, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for use of the MeMed BV® test on whole blood samples on the point-of-need MeMed Key® analyzer to help healthcare providers distinguish between bacterial and viral infections in 15 minutes.

July 19, 2023

·

2 min read

Business

Beckman Coulter and MeMed to Expand Access to Proven Host Immune Response Diagnostic Able to Distinguish Between Bacterial and Viral Infections

Beckman Coulter Diagnostics announced today a strategic partnership to jointly develop and commercialize the proven MeMed BV® test, a host immune response diagnostic that is able to distinguish between bacterial and viral infections for use on the Access Family of Immunoassay Analyzers.

January 31, 2023

·

5 min read

Policy

Radical Imaging Announces FDA Clearance for FlexView Diagnostic, its SaaS Image Viewer for Diagnostic Use.

Radical Imaging, a trailblazer in medical imaging viewer solutions, proudly announces that FlexView Diagnostic, its SaaS web DICOM viewer product, received FDA clearance for diagnostic use.

June 24, 2024

·

2 min read

Pharm Country

Quest Diagnostics Releases 2023 Corporate Responsibility Report

Quest Diagnostics, a leader in diagnostic information services, released its 2023 Corporate Responsibility Report.

June 27, 2024

·

3 min read

Deals

Quest Diagnostics Completes Acquisition of Select PathAI Diagnostics’ Lab Assets from PathAI, Accelerating Adoption of AI and Digital Pathology to Speed Cancer Diagnosis

Quest Diagnostics, a leader in diagnostic information services, announced that it has completed its previously announced acquisition of PathAI Diagnostics from PathAI, with the goal to accelerate the adoption of AI and digital pathology to improve the diagnosis of cancer and other diseases.

June 11, 2024

·

3 min read

Genetown

Clinical data published in Clinical Microbiology and Infection support use of MeMed’s test in reducing antibiotic overuse in children

MeMed, a leader in the emerging field of advanced host-response technologies, today announces positive results from AutoPilot, a prospective, multicenter study, that evaluated performance of MeMed’s test in distinguishing between bacterial and viral infections.

December 1, 2021

·

4 min read

Business

Mosaic Diagnostics Appoints Healthcare Industry Veteran Rob Rebak as CEO

Mosaic Diagnostics is pleased to announce the appointment of Rob Rebak as Chief Executive Officer.

June 27, 2024

·

3 min read